SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 683.98+1.3%12:55 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: CuttingEdge Bio who wrote (2866)3/26/2020 12:19:10 PM
From: Miljenko Zuanic  Read Replies (1) of 3557
 
Is that possibility?
Before bringing *sarcasm* to the field, let evaluate FACTS and how that may play in new field, going forward. All of ass want bios to be successful in this nCoV task, for the sake of the US/W- economy and been-well future of all constituents.

So, any explanation why was (Ab-MoA, secondary effects, ebola mechanisms of killing cells,...) REGN cocktail so effective in ebola-infections? Definitely, ebola is more dangerous virus than nCoV, so one would expect higher rate of efficacy? Right?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News